Product Description

For use as a sedative and analgesic in dogs to facilitate clinical examinations, clinical procedures and minor surgical procedures.

Features & Benefits

• For intramuscular (IM) injection in dogs only
• Short time to onset of sedation of 5-15 minutes
• Short duration of sedation of ~45 minutes in most dogs
• Available in 10 mL multi-dose glass vials
• Each mL contains 0.5 mg medetomidine hydrochloride and 10 mg vatinoxan hydrochloride; and when indicated, can be reversed with atipamezole hydrochloride
• In a field study, dogs treated with Zenalpha had a shorter time to onset of sedation, shorter duration of sedation (recovered quicker), and less cardiovascular and respiratory depression and adverse reactions compared to dogs administered dexmedetomidine in the control group
• Backed by the Dechra Veterinary Technical and Sales Support Teams